Key Takeaways CVS Health executives and hedge fund Glenview Capital Management were reportedly planning to meet today to discuss a shakeup of the pharmacy and health care company's operations.The Wall Street Journal said the move suggests that Glenview founder and CEO Larry Robbins has confidence he can get changes made.

CVS Health Corp.’s stock rose 2.6% Monday after a report surfaced of a meeting between the health-care company and its major hedge-fund investor, Glenview Capital Management. CVS’s stock rose $1.65 to $63.

A major investor is reportedly meeting with CVS executives today amid growing impatience with the company's financial performance.